13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

(c) Transactions by the Reporting Persons (on behalf of the Investment Vehicles) effected during the past 60 days
are set forth in Schedule A below and such information is incorporated herein by reference.

(d) The disclosure regarding the relationship between
the Reporting Persons in Item 2(c) of this Schedule 13D is incorporated by reference herein. All securities reported in this Schedule 13D are directly held by the Investment Vehicles, all of which are investment management clients of Scopia
Capital. None of the Investment Vehicles individually directly holds more than 5% of the Issuers outstanding shares of Common Stock. The limited partners of (or investors in) each of the Investment Vehicles have the right to participate in the
receipt of dividends from, or proceeds from the sale of, the shares of Common Stock held for the accounts of their respective Investment Vehicles in accordance with their respective limited partnership interests (or investment percentages) in their
respective Investment Vehicles.

(e) Not applicable.

None.